Is Genasys, Inc. overvalued or undervalued?

As of 9 May 2022, Genasys, Inc. has moved from a valuation grade of very expensive to risky. The company is currently assessed as overvalued given its significant financial challenges, including a P/E ratio that is not applicable due to losses, a Price to Book Value of 10.09, and an EV to EBITDA of -4.19. Additionally, the company's ROCE and ROE are severely negative at -167.34% and -350.86%, respectively, indicating poor profitability and efficiency.
In comparison to its peers, Genasys, Inc. stands out unfavorably; for instance, Radware Ltd. has a P/E ratio of 128.27 and an EV to EBITDA of 89.08, reflecting a more robust valuation. Other risky peers like Allot Ltd. show even worse metrics, with a P/E of -94.71. The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -40.77% compared to the index's 2.44%. Overall, Genasys, Inc. appears to be overvalued in the current market context.